Bill Sponsor
House Bill 1076
118th Congress(2023-2024)
Preventing the Financing of Illegal Synthetic Drugs Act
Active
Active
Passed House on May 22, 2023
Overview
Text
Introduced
Feb 17, 2023
Latest Action
May 30, 2023
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1076
Congress
118
Policy Area
Government Operations and Politics
Government Operations and Politics
Primary focus of measure is government administration, including agency organization, contracting, facilities and property, information management and services; rulemaking and administrative law; elections and political activities; government employees and officials; Presidents; ethics and public participation; postal service. Measures concerning agency appropriations and the budget process may fall under Economics and Public Finance policy area.
Sponsorship by Party
House Votes (1)
Senate Votes (0)
checkPassed on May 22, 2023
Question
On Motion to Suspend the Rules and Pass, as Amended
Status
Passed
Type
Roll Call Vote
Roll Call Vote
A vote that records the individual position of each Member who voted. Such votes occurring on the House floor (by the "yeas and nays" or by "recorded vote") are taken by electronic device. The Senate has no electronic voting system; in such votes, Senators answer "yea" or "nay" as the clerk calls each name aloud. Each vote is compiled by clerks and receives a roll call number (referenced in Congress.gov as a "Record Vote" [Senate] or "Roll no." [House]).
Roll Call Type
2/3 Yea-And-Nay
Roll Number
228
House Roll Call Votes
Summary

Preventing the Financing of Illegal Synthetic Drugs Act

This bill requires the Government Accountability Office to carry out a study on illicit financing in connection with the trafficking of synthetic drugs, including fentanyl and methamphetamine, fentanyl- and methamphetamine-related substances, Captagon, and fentanyl and methamphetamine precursors, and to report to Congress.

Text (4)
May 30, 2023
May 22, 2023
May 22, 2023
February 17, 2023
Actions (18)
05/30/2023
Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
05/22/2023
Motion to reconsider laid on the table Agreed to without objection.
05/22/2023
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228).
05/22/2023
Passed/agreed to in House On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 402 - 2 (Roll no. 228). (text: CR H2469)
05/22/2023
Considered as unfinished business.
05/22/2023
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
05/22/2023
DEBATE - The House proceeded with forty minutes of debate on H.R. 1076.
05/22/2023
Considered under suspension of the rules.
05/22/2023
Mr. Luetkemeyer moved to suspend the rules and pass the bill, as amended.
05/22/2023
Placed on the Union Calendar, Calendar No. 55.
05/22/2023
Committee on Energy and Commerce discharged.
05/22/2023
Committee on the Judiciary discharged.
05/22/2023
Reported (Amended) by the Committee on Financial Services. H. Rept. 118-75, Part I.
02/28/2023
Ordered to be Reported in the Nature of a Substitute (Amended) by Voice Vote.
02/28/2023
Committee Consideration and Mark-up Session Held.
02/24/2023
Referred to the Subcommittee on Health.
02/17/2023
Referred to the Committee on Financial Services, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
02/17/2023
Introduced in House
Public Record
Record Updated
Mar 18, 2024 8:51:43 PM